Advanced Biomed sells Hong Kong subsidiary for $23,000

8 months ago 85

Skip to navigation Skip to main contented Skip to close file

TipRanks

Wed, December 31, 2025 astatine 9:25 AM CST 1 min read

Advanced Biomed (ADVB) entered into an statement with an unrelated 3rd party, Wei Ha Hui, pursuant to which the Company agreed to merchantability 100% of the issued and outstanding shares of Advanced Biomed Limited, a Hong Kong institution and a wholly owned subsidiary of the Company, for an aggregate acquisition terms of $23,000 based connected a valuation study commissioned by the Company, taxable to the presumption and conditions acceptable distant successful the Agreement. All intelligence spot owned by the Hong Kong subsidiary, including intelligence spot owned by Shanghai Sglcell Biotech, a wholly owned subsidiary of the Hong Kong subsidiary, was transferred to the Buyer astatine the closing of this transaction connected December 23.

Unlock hedge fund-level information and almighty investing tools for smarter, sharper decisions
Stay up of the marketplace with the latest quality and investigation and maximize your portfolio's potential

Published archetypal connected TheFly – the eventual root for real-time, market-moving breaking fiscal news. Try Now>>

See the apical stocks recommended by analysts >>

Read More connected ADVB:

Disclaimer & DisclosureReport an Issue

Advanced Biomed Inc. Delays Quarterly Report Filing

Read Entire Article